Weight Gain Management in Patients With Schizophrenia
Status:
Completed
Trial end date:
2003-10-01
Target enrollment:
Participant gender:
Summary
Evaluate the efficacy of nizatidine in reducing/limiting weight gain in patients with
schizophrenia who have been under treatment with olanzapine for at least two months and
evaluate the treatment effects on the Eating Inventory, BPRS, number of treatment, emergent
adverse events, changes in vital signs, laboratory results and extrapyramidal effects.